SEM Select Medical Holdings Corporation

Item 1.01                    Entry into a Material Definitive Agreement.

On September 26, 2016, Concentra Inc. (“Concentra”), the wholly owned subsidiary of Concentra Group Holdings, LLC, a joint venture that Select Medical Corporation (“Select”) created with Welsh, Carson, Anderson & Stowe XII, L.P., and the other parties named therein entered into Amendment No. 1 (the “Amendment”) to Concentra’s first lien credit agreement, dated June 1, 2015, with JPMorgan Chase Bank, N.A., as administrative agent, collateral agent and lender and the other lenders named therein (the “Credit Agreement”).  The Amendment (i) provides for an additional $200.0 million in tranche B term loans that, along with the original tranche B term loans, have a maturity date of June 1, 2022 and (ii) amends certain restrictive covenants to give Concentra greater operational flexibility.  All other material terms and conditions applicable to Concentra’s original tranche B term loan commitments are applicable to the additional tranche B term loans created under the Amendment.  The proceeds from the Amendment were used to prepay in full the second lien term loan facility under Concentra’s second lien credit agreement, dated June 1, 2015, with Deutsche Bank AG, as administrative agent and collateral agent, and the other lenders party thereto.  Select and Select Medical Holdings Corporation are not parties to the Credit Agreement and are not obligors with respect to Concentra’s debt under such agreement.

The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendment.  A copy of the Amendment is attached to this report as Exhibit 10.1 and incorporated by reference herein.